According to the Company Law of the People's Republic of China, the Guidelines for Establishing Independent Director Systems in Listed Companies, the Code of Corporate Governance for Listed Companies, the Shenzhen Stock Exchange Listing Rules, the Self-Regulatory Guidelines for Listed Companies on the Shenzhen Stock Exchange No. 1 - Standard Operations for Main Board Listed Companies, the Rules for Independent Directors of Listed Companies, and other relevant laws, administr
002411SZSE
Independent Directors' Independent Opinion on the 52nd Meeting of the 5th Board of Directors
✨ AI Summary
This document presents the independent opinion of the independent directors of Yan'an Bikan Pharmaceutical Co., Ltd. regarding the proposed application for pre-restructuring to the court. The decision is deemed compliant with legal regulations and the company's articles of association. The independent directors affirm that the decision process is legitimate and does not harm the interests of the company or minority investors.
Summary generated by AI · Always verify with source document
Full Translation
AI Translation· azure_openai
Sign in to read the full translation
Free accounts get 10 full releases per month. Pro subscribers get unlimited access.